Literature DB >> 35074700

Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!

Fleur Cordier1, Joni Van der Meulen2, Nadine van Roy3, Jilke De Wilde4, Herwig van Dijck5, Filip Vanhoenacker6, Marc Lambrechts7, Valentin Noyez8, Koen Van de Vijver9, Liesbeth Ferdinande10, Amélie Dendooven9, Jo Van Dorpe10, David Creytens11.   

Abstract

Case report of malignant pleural mesothelioma with an ALK gene rearrangement, detected by FISH and confirmed by RNA-based next-generation sequencing. The co-occurrence of ALK gene fusions with the more common genetic alterations in CDKN2A, NF2 and BAP1 has, to our best knowledge, not yet been described in malignant mesothelioma. Furthermore, this unexpected finding could suggest a potential target for therapy in this subset of malignant mesotheliomas.
Copyright © 2022 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  ALK fusion; Copy-number variation sequencing; Immunohistochemistry; Molecular techniques; Next-generation sequencing; Pleural mesothelioma

Mesh:

Substances:

Year:  2022        PMID: 35074700     DOI: 10.1016/j.prp.2022.153772

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  1 in total

1.  Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models.

Authors:  Sze-Kwan Lam; Steven Eugene Mutsaers
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.